Wearable Technology Medical Tubing Remote Monitoring & Wearables

Homepage // News Center // Avient Introduces New Water-Based Digital Hybrid Printing Solution With Accelerated Cure Time Avient Introduces New Water-Based Digital Hybrid Printing Solution to the MagnaColours™ Portfolio, MagnaPrint™ Hybrid Fusion Vibrant White, with Accelerated Cure Time Hybrid screen printing, also called digital hybrid screen printing, combines traditional screen printing with digital printing technology.

artery tourniquet E E G W E ARABL E M ANUFACT URE R P A R T S O F E E G H E A D S E T • Compliance with medical regulation USP Class VI • Increase production efficiency with a simple injection process • High transparency with soft touch KEY REQUIREMENTS COMPLIANCE + SOFT TOUCH LEARN MORE Copyright © 2024, Avient Corporation. AVIENT SOLUTION https://www.avient.com/products/thermoplastic-elastomers/versaflex-thermoplastic-elastomers Slide 1: EEG Wearable manufacturer

This eBook will examine high-performance thermoplastics to answer a range of important questions, including the following: • What is the value proposition of these materials? RADIATION RESISTANCE: This property is needed for some medical sterilization techniques and also for components used in nuclear power plants. NO BPA: Most high-performance thermoplastics do not contain BPA (Bisphenol A), which is associated with concerns about possible health effects. » » » » CRITICAL DIFFERENCES What Makes High-Performance Thermoplastics Stand Out?

Avient Site in Taiwan Earns ISO 13485 Accreditation; Fourth Source for MEVOPUR™ ‘Medical-Grade’ Materials Generational Changes, Environmental Concerns, and a New Digital Universe Expected to Drive Color Preferences in 2023

Trendwatch™ Overcoming 5G Component Challenges (English) TrendWatch™ Materials Matter for Adventure Sports Gear - eBook eBook

Trendwatch™ Overcoming 5G Component Challenges (English) Thermoplastic Elastomers in Medical Devices - White Paper Safety factors, barrier properties and applications of TPEs in medical devices

Avient products have not been designed for nor are they promoted or intended for use in: (a) medical devices categorized by either the United States Food and Drug Administration (FDA) or the International Standards Organization (ISO) as an “implant” device; or “Permanent” as defined under US Pharmacopoeia (USP) or ISO standards; or (b) active implantable medical devices as defined in EU Directive 90/385/EEC as amended; or (c) medical devices for “Long Term” use as defined in EU Directive 93/42/EEC as amended. Without limiting the generality of this statement, Avient products shall not be used in any medical device application intended for: (1) exposure to human tissue or body fluids for 30 days or greater; (2) “plastic” (cosmetic or reconstructive) surgery use; (3) reproductive implants or any birth control device; or (4) any critical component in a permanently (greater than 30 days) implanted medical device that supports or sustains human life. It is the responsibility of the medical device manufacturer and the person placing the medical device on the market to ensure compliance of the medical device, including the suitability of all raw materials and components used for its manufacture, and with all applicable laws and regulations. 1.844.4AVIENT www.avient.com

Suitable for a variety of healthcare applications including medical tubing, devices, and equipment. Electrically Conductive Additives for Silicone Enhance silicone materials with a range of electrical conductivity and lower filler loadings suitable for wearable medical device and electrical stimulation applications. Surface Modification Additives for Silicone Reduce tackiness and enhance smoothness of the cured silicone compound for healthcare applications such as medical tubing, catheters, and medical equipment.

eBook Wearable Technology Remote Monitoring & Wearables